Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
Disease Suppression Persists With Ozanimod at 72 Weeks in MS
Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels.
Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Gray matter is targeted in first-attack multiple sclerosis.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
Psychiatric disorders in patients with multiple sclerosis.
Cognitive impairment and cortical degeneration in neuromyelitis optica.
HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis.
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.
Secukinumab shines in small MS trial
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
Multiple sclerosis and sexual dysfunction.
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register.
Psychiatric symptoms in patients with multiple sclerosis.
MULTIPLE SCLEROSIS: MOLECULAR MECHANISMS AND THERAPEUTIC OPPORTUNITIES.
Dilantin (phenytoin) Supplemental Approval Letter
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.

Pages